🇺🇸 United States Country × Condition
acute myeloid leukemia Clinical Trials in United States
Active clinical trials for acute myeloid leukemia with research sites in United States. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 21 // Recruiting: 21 Phases: Phase 4, Phase 2 // Updated: Daily
Total Trials
21
Recruiting Now
21
Country
🇺🇸 United States
Active Trials in United States (21)
NCT06370000 Phase 4
Recruiting
Oral Azacitidine in Transplant-Eligible Patients With Acute Myeloid Leukemia (AML) Suffering From Health-Inequality
Enrollment
12 pts
Country
🇺🇸 United States
Virginia Commonwealth University
View Trial → NCT06815003 Phase 2
Recruiting
Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
Enrollment
35 pts
Country
🇺🇸 United States
City of Hope Medical Center
View Trial → NCT05672147 Phase 1
Recruiting
CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia
Enrollment
27 pts
Country
🇺🇸 United States
City of Hope Medical Center
View Trial → NCT07121140
Recruiting
Home Blood Transfusions
Enrollment
30 pts
Country
🇺🇸 United States
Thomas Jefferson University
View Trial → NCT06672146 Phase 2
Recruiting
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Enrollment
93 pts
Country
🇺🇸 United States
National Cancer Institute (NCI)
View Trial → NCT06128070 Phase 2
Recruiting
Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
Enrollment
40 pts
Country
🇺🇸 United States
City of Hope Medical Center
View Trial → NCT06059391 Phase 2
Recruiting
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
Enrollment
216 pts
Country
🇺🇸 United States
City of Hope Medical Center
View Trial → NCT05564390 Phase 2
Recruiting
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Enrollment
2,000 pts
Country
🇺🇸 United States
National Cancer Institute (NCI)
View Trial → NCT03113643 Phase 1
Recruiting
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Enrollment
72 pts
Country
🇺🇸 United States
Dana-Farber Cancer Institute
View Trial → NCT06448013 Phase 1
Recruiting
A Phase I Study Investigating the Combination of the Menin Inhibitor Ziftomenib With Venetoclax and Gemtuzumab in Pediatric Patients With Acute Myeloid Leukemia
Enrollment
22 pts
Country
🇺🇸 United States
M.D. Anderson Cancer Center
View Trial → NCT05183035 Phase 3
Recruiting
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Enrollment
130 pts
Country
🇺🇸 United States
PedAL BCU, LLC
View Trial → NCT04195633 Phase 2
Recruiting
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
Enrollment
60 pts
Country
🇺🇸 United States
Fred Hutchinson Cancer Center
View Trial → NCT07022678 Phase 3
Recruiting
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
Enrollment
556 pts
Country
🇺🇸 United States
Children's Oncology Group
View Trial → NCT06892158
Recruiting
Massage Impact on Sleep in Pediatric Oncology
Enrollment
70 pts
Country
🇺🇸 United States
Children's Hospital of Philadelphia
View Trial → NCT07306832 Phase 1
Recruiting
A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Enrollment
18 pts
Country
🇺🇸 United States
AbbVie
View Trial → NCT06575296 Phase 1
Recruiting
Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant
Enrollment
27 pts
Country
🇺🇸 United States
City of Hope Medical Center
View Trial → NCT05732103 Phase 1, Phase 2
Recruiting
A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
Enrollment
225 pts
Country
🇺🇸 United States
Chordia Therapeutics, Inc.
View Trial → NCT04986657
Recruiting
Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS
Enrollment
325 pts
Country
🇺🇸 United States
Washington University School of Med...
View Trial → NCT04771130 Phase 1, Phase 2
Recruiting
A Study of BGB-11417 in Participants With Myeloid Malignancies
Enrollment
260 pts
Country
🇺🇸 United States
BeOne Medicines
View Trial → NCT06419634 Phase 1
Recruiting
Study of BMS-986497 (ORM-6151) as a Monotherapy, in Double and Triple Combination With Azacitidine and Venetoclax in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
Enrollment
105 pts
Country
🇺🇸 United States
Bristol-Myers Squibb
View Trial → NCT04774393 Phase 1, Phase 2
Recruiting
Decitabine/Cedazuridine and Venetoclax in Combination With Ivosidenib or Enasidenib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Enrollment
84 pts
Country
🇺🇸 United States
M.D. Anderson Cancer Center
View Trial → Frequently Asked Questions
How many acute myeloid leukemia clinical trials are active in United States?
There are currently 21 active clinical trials for acute myeloid leukemia with sites in United States, of which 21 are actively recruiting patients.
How can I join a acute myeloid leukemia clinical trial in United States?
To join a acute myeloid leukemia clinical trial in United States, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in United States directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are acute myeloid leukemia trials in United States?
Active acute myeloid leukemia trials in United States span Phase 4, Phase 2, Phase 1, Phase 3, Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology